Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HUNTINGTON DISEASE-LIKE 3 (disorder)

Known as: HDL3, HUNTINGTON DISEASE-LIKE 3, Huntington Disease-Like Neurodegenerative Disorder, Autosomal Recessive 
 
National Institutes of Health

Related topics

Related topics

13 relations
Abnormal pyramidal signsAbnormality of extrapyramidal motor functionAtaxiaAutosomal recessive inheritance
Expand

Broader (1)

Huntington Disease

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function
Objective—Recent proteomic studies have identified multiple proteins that coisolate with human HDL. We hypothesized that distinct… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2009
Highly Cited
2009
HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and…
Objectives—Small dense HDL3 particles of defined lipidome and proteome potently protect atherogenic LDL against free radical… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1998
Highly Cited
1998
Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells.
We have previously reported that high density lipoproteins (HDLs) inhibit the cytokine-induced expression of adhesion molecules… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
1998
Highly Cited
1998
HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol…
We demonstrate that physiological concentrations of HDL3 inhibit the thrombin-induced platelet fibrinogen binding and aggregation… Expand
Highly Cited
1994
Highly Cited
1994
Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men.
In addition to their use as replacement therapy for hypogonadal males, androgens, particularly testosterone (T), are being… Expand
Highly Cited
1991
Highly Cited
1991
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
BACKGROUND The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and… Expand
Highly Cited
1991
Highly Cited
1991
HDL, HDL2, and HDL3 Subfractions, and the Risk of Acute Myocardial Infarction: A Prospective Population Study in Eastern Finnish Men
BackgroundWe investigated the association of cholesterol concentrations in serum high density lipoprotein (HDL) and its… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
1989
Review
1989
Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.
Probucol is a lipid-regulating agent structurally dissimilar to other known agents, with a unique pharmacodynamic and clinical… Expand
  • figure 1
  • figure 2
  • table II
  • table II
  • table III
Highly Cited
1984
Highly Cited
1984
The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study.
High-density lipoproteins (HDL) in plasma may be divided into two subfractions: less dense HDL2, the concentration of which… Expand
Highly Cited
1984
Highly Cited
1984
Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.
In this study, we have investigated the effects of alimentary lipemia in 15 normotriglyceridemic individuals on high density… Expand
  • table I
  • figure 1
  • figure 3
  • table II
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE